The mortality rate from trachea, bronchus, or lung malignant neoplasms in the US shows a declining trend from 2024 to 2028. The forecasted data suggests a consistent yearly decrease, with a significant drop from 32.9 deaths per hundred thousand persons in 2024 to 25.2 in 2028. This indicates a Compound Annual Growth Rate (CAGR) of -6.45% over this five-year period, highlighting effective interventions or changes in smoking patterns. Comparatively, in 2023, the rate stood higher, suggesting that the reduction trend began beforehand and is on a steady decline.
Future trends to watch for include advancements in cancer therapies, increased tobacco cessation efforts, and potential impacts of environmental policy changes. These factors could further influence the downward trajectory of mortality rates.
